(C22.1) Malignant neoplasm: intrahepatic bile duct carcinoma

More details coming soon

Icon
1 879 327 in individuals diagnosis malignant neoplasm: intrahepatic bile duct carcinoma confirmed
Icon
963 698 deaths with diagnosis malignant neoplasm: intrahepatic bile duct carcinoma
Icon
51% mortality rate associated with the disease malignant neoplasm: intrahepatic bile duct carcinoma

Diagnosis malignant neoplasm: intrahepatic bile duct carcinoma is diagnosed Men are 28.68% more likely than Women

1 209 147

Men receive the diagnosis malignant neoplasm: intrahepatic bile duct carcinoma

629 744 (52.1 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
670 180

Women receive the diagnosis malignant neoplasm: intrahepatic bile duct carcinoma

333 954 (49.8 %)

Died from this diagnosis.

Risk Group for the Disease malignant neoplasm: intrahepatic bile duct carcinoma - Men aged 65-69 and Women aged 70-74

Icon
In Men diagnosis is most often set at age 0-95+
Icon
in in men, the disease manifests at any agein in women, the disease manifests at any age
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features malignant neoplasm: intrahepatic bile duct carcinoma

Icon
Absence or low individual and public risk
Icon

Malignant neoplasm: intrahepatic bile duct carcinoma - what does this mean

Malignant neoplasm of the intrahepatic bile duct is a rare cancer of the bile ducts, which are the small tubes that carry bile from the liver to the small intestine. it occurs when malignant cells form in the inner lining of the bile ducts, causing them to become blocked and leading to a buildup of bile in the liver. this can lead to jaundice, abdominal pain, and other symptoms.

What happens during the disease - malignant neoplasm: intrahepatic bile duct carcinoma

Malignant neoplasm of the intrahepatic bile duct is characterized by an abnormal growth of cells that invade and destroy the normal tissue of the bile ducts. this growth is caused by a variety of factors, including genetic mutations, environmental influences, and exposure to certain chemicals or radiation. as the cancerous cells continue to grow, they can spread to other parts of the body, leading to further complications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Imaging tests (CT scan, MRI, ultrasound)
  • Liver function tests
  • Tumor markers (CEA, CA 19-9)
  • Biopsy
  • Endoscopic retrograde cholangiopancreatography (ERCP)
  • Endoscopic ultrasound (EUS)

Treatment and Medical Assistance

Main goal of the treatment: To reduce the size of the tumor and improve the patient's quality of life.
  • Surgery to remove the tumor
  • Chemotherapy to shrink the tumor
  • Radiation therapy to target the tumor
  • Immunotherapy to stimulate the immune system to fight the cancer cells
  • Targeted therapy to inhibit the growth of the cancer cells
  • Clinical trials to test new treatments
  • Pain management to reduce symptoms
Icon
16 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Malignant neoplasm: intrahepatic bile duct carcinoma - Prevention

The best way to prevent intrahepatic bile duct carcinoma is to reduce risk factors such as smoking, heavy alcohol consumption, and chronic viral hepatitis infections. regular screenings, early detection, and prompt treatment of precancerous lesions are also important in preventing this type of cancer.